| Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind … HGM Heijerman, EF McKone, DG Downey, E Van Braeckel, SM Rowe, ... The Lancet 394 (10212), 1940-1948, 2019 | 1001 | 2019 |
| Triple Therapy for Cystic Fibrosis Phe508del–Gating and –Residual Function Genotypes PJ Barry, MA Mall, A Álvarez, C Colombo, KM de Winter-De Groot, I Fajac, ... New England Journal of Medicine 385 (9), 815-825, 2021 | 180 | 2021 |
| Safety effects of exclusive and concurrent signal phasing for pedestrian crossing Y Zhang, SA Mamun, JN Ivan, N Ravishanker, K Haque Accident Analysis & Prevention 83, 26-36, 2015 | 55 | 2015 |
| A study of pedestrian compliance with traffic signals for exclusive and concurrent phasing JN Ivan, K McKernan, Y Zhang, N Ravishanker, SA Mamun Accident Analysis & Prevention 98, 157-166, 2017 | 28 | 2017 |
| Non-respiratory health-related quality of life in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor I Fajac, C Daines, I Durieu, JL Goralski, H Heijerman, C Knoop, C Majoor, ... Journal of Cystic Fibrosis 22 (1), 119-123, 2023 | 22 | 2023 |
| Identifying association between pedestrian safety interventions and street-crossing behavior considering demographics and traffic context S Mamun, FJ Caraballo, JN Ivan, N Ravishanker, RM Townsend, Y Zhang Journal of Transportation Safety & Security 12 (3), 441-462, 2020 | 15 | 2020 |
| Modeling financial durations using penalized estimating functions Y Zhang, J Zou, N Ravishanker, A Thavaneswaran Computational statistics & data analysis 131, 145-158, 2019 | 9 | 2019 |
| Phase 1 study to assess the safety and pharmacokinetics of elexacaftor/tezacaftor/ivacaftor in subjects without cystic fibrosis with moderate hepatic impairment L Viswanathan, E Bachman, S Tian, N Ahluwalia, Y Zhang, HS Bernstein, ... European Journal of Drug Metabolism and Pharmacokinetics 47 (6), 817-825, 2022 | 7 | 2022 |
| Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open … CL Daines, E Tullis, S Costa, RW Linnemann, MA Mall, EF McKone, ... European Respiratory Journal 62 (6), 2023 | 4 | 2023 |
| An application of the tau-path method in highway safety Y Zhang, N Ravishanker, JN Ivan, SA Mamun Journal of the Indian Society for Probability and Statistics 20, 117-139, 2019 | 4 | 2019 |
| A simple and efficient statistical approach for designing an early phase II clinical trial: ordinal linear contrast test Y Zhang, Q Deng, S Wang, N Ting New Advances in Statistics and Data Science, 179-196, 2017 | 3 | 2017 |
| Structural break detection in financial durations Y Zhang, N Ravishanker, J Zou Applied Stochastic Models in Business and Industry 34 (6), 992-1006, 2018 | 1 | 2018 |
| A confirmatory basket design considering non-inferiority and superiority testing Y Zhang, C Chu, RA Beckman, L Gao, G Laird, B Yi Journal of Biopharmaceutical Statistics 34 (2), 205-221, 2024 | | 2024 |
| Structure Learning and Break Detection in High-Frequency Data Y Zhang | | 2017 |
| A Semiparametric Statistical Approach to Evaluate Conflict Severity As a Surrogate for Crashes in the Context Of Pedestrian Safety Y Zhang, N Ravishanker, JN Ivan, SA Mamun Transportation Research Board 96th Annual MeetingTransportation Research Board, 2017 | | 2017 |
| Social network effects on attitudes about pedestrian street crossing behaviour: preliminary findings JN Ivan, N Ravishanker, R Townsend, S Mamum, F Caraballo, Y Zhang 17th International Conference Road Safety On Five Continents (RS5C 2016 …, 2016 | | 2016 |
John N. IvanProfessor of Civil & Environmental Engineering, University of ConnecticutVerified email at uconn.edu
